Can a 6-Minute video ease Chemotherapy's toll?
NCT ID NCT07769931
First seen Aug 18, 2026 · Last updated Aug 21, 2026 · Updated 3 times
Summary
This trial tests whether a short, visual education method called PechaKucha can help people receiving chemotherapy manage their symptoms and improve their quality of life. Participants are randomly assigned to receive either this special video-based education or the standard education. The video covers common chemotherapy side effects like pain, nausea, fatigue, and anxiety. Researchers will compare symptom severity and quality of life between the two groups before and one week after the education.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- PechaKucha-based symptom management education
- What this could lead to
- If effective, this short, visual education method could become a simple, low-cost way to help chemotherapy patients better manage symptoms and improve their quality of life.
- What could go wrong
- This is a small, early-stage trial, and the benefit of a brief educational video may be limited. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 140 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Willing to participate in the study. * Currently receiving treatment in the chemotherapy unit. * Aged 18 years or older, willing to participate, and able to communicate effectively. Exclusion Criteria: * Being under 18 years of age. * Having cognitive or communication difficulties. * Having a visual or hearing impairment. * Being in an advanced or terminal stage of the disease. * Having a physical or psychological condition that prevents active participation in the educational process.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
SBÜ Kanuni Sultan Süleyman E.A.H
RECRUITINGIstanbul, 34520, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can colorectal surgery patients go home in two days?
- Can a personal navigator help young cancer patients through treatment?
- Can a smartwatch predict which cancer patients return to hospital?
- Two-Drug combo aims to stall advanced breast cancer
- Blood thinner flush could boost tumor biopsy success
- Could a frailty score predict which older cancer patients survive intensive care?